Increased Plasma S-Nitrosothiol Concentrations Predict Cardiovascular Outcomes among Patients with End-Stage Renal Disease: A Prospective Study

Journal of the American Society of Nephrology

Volumn 15, Issue 2, 2004, Pages 470-476

  Massy, Ziad A ^a,b   Fumeron, Christine ^c   Borderie, Didier ^d   Tuppin, Philippe ^e   Nguyen Khoa, Thao ^a   Benoit, Marie Odile ^f   Jacquot, Christian ^g   Buisson, Claude ^c   Drüeke, Tilman B ^a   Ekindjian, Ohvanesse G ^d   Lacour, Bernard ^a   Iliou, Marie Christine ^h  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c Association pour l'Utilisation du Rein Artificiel   (France)

^d Cochin Hospital ^*  (France)

^e French Transplantation Agency   (France)

^f Biochemistry Laboratory   (France)

^g Division of Nephrology   (France)

^h HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

S NITROSOTHIOL;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PULSE PRESSURE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SURVIVAL RATE; TIME;

CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; S-NITROSOTHIOLS; SURVIVAL RATE; TIME FACTORS;

EID: 4444295662     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000106716.22153.BB     Document Type: Article

References (40)

1. Jungers P, Nguyen-Khoa T, Joly D, Choukroun G, Witko-Sarsat V, Massy ZA: Atherosclerotic complications in chronic renal failure: Epidemiology and predictive factors. Adv Nephrol 30: 177-199, 2000
2. London GM, Drüeke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 51: 1678-1695, 1997
3. Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN: Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83: 205-209, 2000
4. Joannides R, Bakkali EH, Le Roy F, Rivault O, Godin M, Moore N, Fillastre JP, Thuillez C: Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Nephrol Dial Transplant 12: 2623-2628, 1997
5. van Guldener C, Lambert J, Janssen MJ, Donker AJ, Stehouwer CD: Endothelium-dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients. Nephrol Dial Transplant 12[Suppl 2]: 14-18, 1997
6. Kielstein JT, Boger RH, Bode-Boger SM, Schaffer J, Barbey M, Koch KM, Frolich JC: Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: Relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999
7. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Boger R: Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62: 339-345, 2002
8. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R: Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study. Lancet 358: 2113-2117, 2001
9. Schmidt RJ, Baylis C: Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58: 1261-1266, 2000
10. Lau T, Owen W, Yu YM, Noviski N, Lyons J, Zurakowski D, Tsay R, Ajami A, Young VR, Castillo L: Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 105: 1217-1225, 2000
11. Massy ZA, Borderie D, Nguyen-Khoa T, Drüeke TB, Ekindjian OG, Lacour B: Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 18: 153-157, 2003
12. Rassaf T, Kleinbongard P, Preik M, Dejam A, Gharini P, Lauer T, Erckenbrecht J, Duschin A, Schulz R, Heusch G, Feelisch M, Kelm M: Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: Experimental and clinical study on the fate of NO in human blood. Circ Res 91: 470-477, 2002
13. Jourd'heuil D, Jourd'heuil FL, Feelisch M: Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide: Evidence for a free radical mechanism. J Biol Chem 278: 15720-15726, 2003
14. Suliman ME, Anderstam B, Lindholm B, Bergstrom J: Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant 12: 2332-2338, 1997
15. Loscalzo J: Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88: 756-762, 2001
16. De Man JG, De Winter BY, Moreels TG, Herman AG, Pelckmans PA: S-Nitrosothiols and the nitrergic neurotransmitter in the rat gastric fundus: Effect of antioxidants and metal chelation. Br J Pharmacol 123: 1039-1046, 1998
17. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey G, Witko-Sarsat V, Drüeke TB, Lacour B, Thevenin M: Oxidative stress and haemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16: 335-340, 2001
18. Tyurin VA, Liu SX, Tyurina YY, Sussman NB, Hubel CA, Roberts JM, Taylor RN, Kagan VE: Elevated levels of S-nitro-soalbumin in preeclampsia plasma. Circ Res 88: 1210-1215, 2001
19. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, Miller DH, Reis G, Alderman MH, Laragh JH: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 4: 1222-1230, 1984
20. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4: 1205-1213, 1993
21. Borderie D, Massy ZA, Nguyen-Khoa T, Drüeke TB, Ekindjian OG, Lacour B: Are plasma S-nitrosothiol levels elevated in chronic renal failure? Nephrol Dial Transplant 18: 2199-2201, 2003
22. Wlodek PJ, Kucharczyk J, Sokolowska MM, Milkowski A, Markiewicz A, Smolenski OB, Wlodek LB: Alteration in plasma levels of nonprotein sulfhydryl compounds and S-nitrosothiols in chronic renal failure patients. Clin Chim Acta 327: 87-94, 2003
23. Giustarini D, Milzani A, Colombo R, Dalle-Donne I, Rossi R: Nitric oxide and S-nitrosothiols in human blood. Clin Chim Acta 330: 85-98, 2003
24. Tozawa M, Iseki K, Iseki C, Takishita S: Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 61: 717-726, 2002
25. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM, Owen WF Jr: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002
26. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H: Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17: 1713-1724, 2002
27. Fitch RM, Vergona R, Sullivan ME, Wang YX: Nitric oxide synthase inhibition increases aortic stiffness measured by pulse wave velocity in rats. Cardiovasc Res 51: 351-358, 2001
28. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR: Nitric oxide regulates local arterial distensibility in vivo. Circulation 105: 213-217, 2002
29. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P: Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension 38: 1049-1053, 2001
30. McVeigh GE, Allen PB, Morgan DR, Hanratty CG, Silke B: Nitric oxide modulation of blood vessel tone identified by arterial waveform analysis. Clin Sci 100: 387-393, 2001
31. Recchia FA, Senzaki H, Saeki A, Byrne BJ, Kass DA: Pulse pressure-related changes in coronary flow in vivo are modulated by nitric oxide and adenosine. Circ Res 79: 849-856, 1996
32. Crane MS, Ollosson R, Moore KP, Rossi AG, Megson IL: Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function. J Biol Chem 277: 46858-46863, 2002
33. de Belder AJ, MacAllister R, Radomski MW, Moncada S, Vallance PJ: Effects of S-nitroso-glutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation. Cardiovasc Res 28: 691-694, 1994
34. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T: Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 99: 1141-1146, 1999
35. Kielstein JT, Bode-Boger SM, Frolich JC, Ritz E, Haller H, Fliser D: Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 107: 1891-1895, 2003
36. Vallance P: Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 358: 2096-2097, 2001
37. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C: Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant 18: 1272-1280, 2003
38. Muller B, Kleschyov AL, Alencar JL, Vanin A, Stoclet JC: Nitric oxide transport and storage in the cardiovascular system. Ann NY Acad Sci 962: 131-139, 2002
39. Hogg N: Biological chemistry and clinical potential of S-nitrosothiols. Free Radical Biol Med 28: 1478-1486, 2000
40. Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ: Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int 63: 1433-1442, 2003